Bevacizumab-Adcd
Bevacizumab-Adcd is a biosimilar (pin-variant) of bevacizumab, a monoclonal antibody designed to inhibit tumor growth by blocking angiogenesis. It is used in the treatment of various cancers and is typically administered via intravenous infusion.
Bevacizumab-Adcd is a cancer treatment biosimilar that inhibits blood vessel formation to tumors.
Key facts at a glance
- RxNorm
- 2627648
- Generic
- Bevacizumab-Adcd
- Class
- pin-variant
- Brands
- Vegzelma
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Treats various metastatic or advanced cancers including colorectal cancer, non-small cell lung cancer, renal cell carcinoma, glioblastoma, cervical cancer, ovarian/fallopian tube/peritoneal cancer, and hepatocellular carcinoma. Specific approved indications may vary by region and regulatory approval status for biosimilar versions.
As a VEGF inhibitor, this medication binds to vascular endothelial growth factor (VEGF), preventing it from interacting with its receptors on endothelial cells. This action inhibits the formation of new blood vessels (angiogenesis) that supply tumors with oxygen and nutrients, thereby slowing tumor growth and progression.
Administered as an intravenous infusion. Common side effects include hypertension, proteinuria, bleeding, impaired wound healing, and gastrointestinal perforation risk. Requires monitoring of blood pressure and renal function. Should not be used during pregnancy. As a biosimilar, it demonstrates similarity to the reference product in terms of efficacy, safety, and quality characteristics.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy